Efficacy and Safety of Lixisenatide Once Daily Versus Exenatide Twice Daily in Type 2 Diabetes Inadequately Controlled on Metformin: A 24-week, randomized, open-label, active-controlled study (GetGoal-X)
Main Authors: | , , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
American Diabetes Association
2013
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3781502/ |